Cartesian Therapeutics, Inc.

DB:1S70 Stock Report

Market Cap: €140.2m

Cartesian Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

DB:1S70 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
06 Jan 26Sell€20,846Milos MiljkovicIndividual3,573€5.83
06 Jan 26Sell€61,791Blaine DavisIndividual10,591€5.83
06 Jan 26Sell€138,657Carsten BrunnIndividual23,766€5.83
04 Dec 25Buy€176,471Timothy BarabeIndividual30,000€5.88
11 Apr 25Buy€1,344,383Timothy SpringerIndividual149,075€9.65
20 Mar 25Buy€1,263,656Timothy SpringerIndividual89,863€14.37

Insider Trading Volume

Insider Buying: 1S70 insiders have sold more shares than they have bought in the past 3 months.


Ownership Breakdown

What is the ownership structure of 1S70?
Owner TypeNumber of SharesOwnership Percentage
Private Companies1,431,3905.5%
General Public3,374,49313%
Institutions5,912,49522.7%
Individual Insiders15,285,22858.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 84.66% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
37%
Timothy Springer
9,628,915€51.9m0.05%no data
19.5%
Murat Kalayoglu
5,062,259€27.3m0.09%no data
5.26%
FMR LLC
1,366,989€7.4m-36.6%no data
4.03%
Schooner Century Fund Llc
1,047,594€5.6m0%no data
2.5%
BlackRock, Inc.
649,341€3.5m-0.69%no data
2.17%
Artal Group S.A.
563,272€3.0m0%0.07%
2.08%
The Vanguard Group, Inc.
541,228€2.9m3.94%no data
1.6%
HBM Partners Ltd.
415,234€2.2m0%0.23%
1.48%
Thirsty Brook 2010 Irrevocable Trust
383,796€2.1m0%no data
1.46%
MPM BioImpact LLC
380,000€2.0m-44.6%0.23%
1%
Erste Asset Management GmbH
260,011€1.4m0%0.01%
0.94%
Michael Singer
243,993€1.3m-5.95%no data
0.93%
Geode Capital Management, LLC
241,829€1.3m10.5%no data
0.88%
683 Capital Management, LLC
230,000€1.2m5.02%0.12%
0.76%
State Street Global Advisors, Inc.
197,666€1.1m1.75%no data
0.66%
Privium Fund Management BV
172,500€930.1k0%0.15%
0.35%
Northern Trust Global Investments
91,289€492.2k10.1%no data
0.33%
Marshall Wace LLP
84,806€457.3k2.63%no data
0.3%
Baharak Asefzadeh
78,634€424.0k0%no data
0.3%
GSA Capital Partners LLP
77,227€416.4k-10.3%0.04%
0.27%
Citadel Advisors LLC
70,524€380.3k-41.7%no data
0.26%
UBS Asset Management AG
67,341€363.1k577%no data
0.23%
Carsten Brunn
59,637€321.6k97.2%no data
0.2%
Timothy Barabe
52,388€282.5k194%no data
0.19%
Emily English
49,015€264.3k92.8%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/02/12 15:38
End of Day Share Price 2026/02/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cartesian Therapeutics, Inc. is covered by 10 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Julian HarrisonBTIG
John NewmanCanaccord Genuity
Kristen KluskaCantor Fitzgerald & Co.